Your browser doesn't support javascript.
loading
Lifetime risk, life expectancy, and years of life lost to type 2 diabetes in 23 high-income jurisdictions: a multinational, population-based study.
Tomic, Dunya; Morton, Jedidiah I; Chen, Lei; Salim, Agus; Gregg, Edward W; Pavkov, Meda E; Arffman, Martti; Balicer, Ran; Baviera, Marta; Boersma-van Dam, Elise; Brinks, Ralph; Carstensen, Bendix; Chan, Juliana C N; Cheng, Yiling J; Fosse-Edorh, Sandrine; Fuentes, Sonsoles; Gardiner, Hélène; Gulseth, Hanne L; Gurevicius, Romualdas; Ha, Kyoung Hwa; Hoyer, Annika; Jermendy, György; Kautzky-Willer, Alexandra; Keskimäki, Ilmo; Kim, Dae Jung; Kiss, Zoltán; Klimek, Peter; Leventer-Roberts, Maya; Lin, Chun-Yi; Lopez-Doriga Ruiz, Paz; Luk, Andrea O Y; Ma, Stefan; Mata-Cases, Manel; Mauricio, Dídac; McGurnaghan, Stuart; Imamura, Tomoaki; Paul, Sanjoy K; Peeters, Anna; Pildava, Santa; Porath, Avi; Robitaille, Cynthia; Roncaglioni, Maria Carla; Sugiyama, Takehiro; Wang, Kang-Ling; Wild, Sarah H; Yekutiel, Naama; Shaw, Jonathan E; Magliano, Dianna J.
Afiliación
  • Tomic D; Baker Heart and Diabetes Institute, Melbourne, VIC, Australia; School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia. Electronic address: Dee.Tomic@baker.edu.au.
  • Morton JI; Baker Heart and Diabetes Institute, Melbourne, VIC, Australia; School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia; Centre for Medicine Use and Safety, Monash University, Melbourne, VIC, Australia.
  • Chen L; Baker Heart and Diabetes Institute, Melbourne, VIC, Australia.
  • Salim A; Baker Heart and Diabetes Institute, Melbourne, VIC, Australia; Melbourne School of Population and Global Health, University of Melbourne, Melbourne, VIC, Australia; School of Mathematics and Statistics, University of Melbourne, Melbourne, VIC, Australia.
  • Gregg EW; Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK.
  • Pavkov ME; Division of Diabetes Translation, Centers for Diseases Control and Prevention, Atlanta, GA, USA.
  • Arffman M; Welfare State Research and Reform, Finnish Institute for Health and Welfare, Helsinki, Finland.
  • Balicer R; Clalit Research Institute, Clalit Health Services, Tel Aviv, Israel.
  • Baviera M; Laboratory of Cardiovascular Prevention, Mario Negri Institute for Pharmacological Research, IRCCS, Milan, Italy.
  • Boersma-van Dam E; Department of General Practice, Netherlands Institute for Health Services Research, Utrecht, Netherlands.
  • Brinks R; Institute for Biometrics and Epidemiology, German Diabetes Center, Duesseldorf, Germany; Institute for Medical Biometry and Epidemiology, University Witten/Herdecke, Witten, Germany.
  • Carstensen B; Clinical Epidemiology, Steno Diabetes Center Copenhagen, Herlev, Denmark.
  • Chan JCN; Department of Medicine and Therapeutics, Li Ka Shing Institute of Health Sciences, Hong Kong Institute of Diabetes and Obesity, Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong Special Administrative Region, China.
  • Cheng YJ; Division of Diabetes Translation, Centers for Diseases Control and Prevention, Atlanta, GA, USA.
  • Fosse-Edorh S; Department of Non-Communicable Diseases and Trauma, Santé Publique France, Saint-Maurice, France.
  • Fuentes S; Department of Non-Communicable Diseases and Trauma, Santé Publique France, Saint-Maurice, France.
  • Gardiner H; Centre for Surveillance and Applied Research, Public Health Agency of Canada, Ottawa, ON, Canada.
  • Gulseth HL; Department for Chronic Diseases, Norwegian Institute of Public Health, Oslo, Norway.
  • Gurevicius R; Center of Health Information, Institute of Hygiene, Vilnius, Lithuania; Faculty of Public Governance and Business, Mykolas Romeris University, Vilnius, Lithuania.
  • Ha KH; Department of Endocrinology and Metabolism, Ajou University School of Medicine, Suwon, South Korea.
  • Hoyer A; Biostatistics and Medical Biometry, Medical School EWL, Bielefeld University, Bielefeld, Germany.
  • Jermendy G; Third Medical Department, Bajcsy-Zsilinszky Hospital, Budapest, Hungary.
  • Kautzky-Willer A; Department of Medicine III, Endocrinology and Metabolism, Medical University of Vienna, Vienna, Austria; Gender Institute, Gars am Kamp, Austria.
  • Keskimäki I; Welfare State Research and Reform, Finnish Institute for Health and Welfare, Helsinki, Finland; Faculty of Social Sciences, Tampere University, Tampere, Finland.
  • Kim DJ; Department of Endocrinology and Metabolism, Ajou University School of Medicine, Suwon, South Korea.
  • Kiss Z; Second Department of Medicine and Nephrological Center, University of Pécs, Pécs, Hungary.
  • Klimek P; Section for Science of Complex Systems, Medical University of Vienna, Vienna, Austria; Complexity Science Hub Vienna, Vienna, Austria.
  • Leventer-Roberts M; Clalit Research Institute, Clalit Health Services, Tel Aviv, Israel; Department of Pediatrics, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Department of Environmental Medicine and Public Health, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Lin CY; General Clinical Research Center, Taipei Veterans General Hospital, Taipei, Taiwan.
  • Lopez-Doriga Ruiz P; Department for Chronic Diseases, Norwegian Institute of Public Health, Oslo, Norway; Department of Endocrinology, Morbid Obesity and Preventive Medicine, Oslo University Hospital, Oslo, Norway.
  • Luk AOY; Department of Medicine and Therapeutics, Li Ka Shing Institute of Health Sciences, Hong Kong Institute of Diabetes and Obesity, Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong Special Administrative Region, China.
  • Ma S; Epidemiology and Disease Control Division, Public Health Group, Ministry of Health, Singapore.
  • Mata-Cases M; CIBER of Diabetes and Associated Metabolic Diseases, Instituto de Salud Carlos III, Barcelona, Spain; Institut Català de la Salut, Unitat de Suport a la Recerca Barcelona Ciutat, Institut Universitari d'Investigació en Atenció Primària Jordi Gol, Barcelona, Spain.
  • Mauricio D; CIBER of Diabetes and Associated Metabolic Diseases, Instituto de Salud Carlos III, Barcelona, Spain; Institut Català de la Salut, Unitat de Suport a la Recerca Barcelona Ciutat, Institut Universitari d'Investigació en Atenció Primària Jordi Gol, Barcelona, Spain; Department of Endocrinology, Hospit
  • McGurnaghan S; Usher Institute, University of Edinburgh, Edinburgh, UK.
  • Imamura T; Department of Public Health, Health Management and Policy, Nara Medical University, Nara, Japan.
  • Paul SK; Department of Medicine, University of Melbourne, Melbourne, VIC, Australia.
  • Peeters A; Institute for Health Transformation, Deakin University, Melbourne, VIC, Australia.
  • Pildava S; Research and Health Statistics Department, Centre for Disease Prevention and Control, Riga, Latvia.
  • Porath A; Research Institute, Maccabi Healthcare Services, Tel Aviv, Israel; Faculty of Health Sciences, Ben Gurion University, Beer-Sheva, Israel.
  • Robitaille C; Centre for Surveillance and Applied Research, Public Health Agency of Canada, Ottawa, ON, Canada.
  • Roncaglioni MC; Laboratory of Cardiovascular Prevention, Mario Negri Institute for Pharmacological Research, IRCCS, Milan, Italy.
  • Sugiyama T; Diabetes and Metabolism Information Center, Research Institute, National Center for Global Health and Medicine, Tokyo, Japan; Institute for Global Health Policy Research, Bureau of International Health Cooperation, National Center for Global Health and Medicine, Tokyo, Japan; Department of Health Se
  • Wang KL; General Clinical Research Center, Taipei Veterans General Hospital, Taipei, Taiwan.
  • Wild SH; Usher Institute, University of Edinburgh, Edinburgh, UK.
  • Yekutiel N; Research Institute, Maccabi Healthcare Services, Tel Aviv, Israel.
  • Shaw JE; Baker Heart and Diabetes Institute, Melbourne, VIC, Australia; School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia.
  • Magliano DJ; Baker Heart and Diabetes Institute, Melbourne, VIC, Australia; School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia.
Lancet Diabetes Endocrinol ; 10(11): 795-803, 2022 11.
Article en En | MEDLINE | ID: mdl-36183736
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 Tipo de estudio: Etiology_studies / Incidence_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male País/Región como asunto: Oceania Idioma: En Revista: Lancet Diabetes Endocrinol Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 Tipo de estudio: Etiology_studies / Incidence_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male País/Región como asunto: Oceania Idioma: En Revista: Lancet Diabetes Endocrinol Año: 2022 Tipo del documento: Article